Mariana Alves Selected Research

Mariana Alves Research Topics

Disease

18	Status Epilepticus (Complex Partial Status Epilepticus) 10/2023 - 01/2016
17	Seizures (Absence Seizure) 10/2023 - 01/2016
16	Epilepsy (Aura) 10/2023 - 01/2016
7	Inflammation (Inflammations) 01/2023 - 01/2016
7	Temporal Lobe Epilepsy 01/2022 - 01/2016
4	Hemorrhage 05/2023 - 01/2020
4	Myocardial Infarction 01/2023 - 01/2020
4	Brain Diseases (Brain Disorder) 01/2021 - 02/2017
3	Hypoxia (Hypoxemia) 02/2023 - 01/2021
3	Neuroinflammatory Diseases 01/2023 - 01/2016
3	Parkinson Disease (Parkinson's Disease) 08/2022 - 01/2020
3	Stroke (Strokes) 08/2021 - 01/2020
3	Brain Injuries (Brain Injury) 01/2021 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2020
3	Pathologic Processes 01/2020 - 01/2016
2	Human Influenza (Influenza) 02/2022 - 01/2021
2	Aortic Dissection 02/2022 - 01/2022
2	Frailty 01/2022 - 01/2021
2	Acute Coronary Syndrome 08/2021 - 01/2021
2	COVID-19 01/2021 - 12/2020
1	Ischemic Stroke 11/2023
1	Atrial Fibrillation 10/2023
1	Dementia (Dementias) 10/2023
1	Cognitive Dysfunction 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021
1	ST Elevation Myocardial Infarction 01/2021
1	Drug Resistant Epilepsy 01/2021
1	Abdominal Aortic Aneurysm 01/2021
1	Infections 12/2020
1	Heart Failure 11/2020
1	Sudden Death 11/2020
1	Bacteriuria 02/2018

Drug/Important Bio-Agent (IBA)

15	Kainic Acid (Kainate)IBA 10/2023 - 01/2016
11	Purinergic P2X7 ReceptorsIBA 01/2023 - 01/2016
11	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2016
4	AnticoagulantsIBA 10/2023 - 01/2021
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 12/2017 - 01/2017
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2021
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2020
2	Vitamin K FDA Link 10/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 10/2023 - 01/2020
2	ElementsIBA 10/2023 - 01/2020
2	Carrier Proteins (Binding Protein)IBA 10/2023 - 01/2020
2	Purinergic P2Y1 ReceptorsIBA 02/2023 - 01/2019
2	JNJ-47965567IBA 01/2023 - 01/2016
2	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 02/2022 - 01/2022
2	Purinergic Receptors (Receptors, Purine)IBA 01/2022 - 01/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 12/2020
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 12/2020
2	Purine NucleosidesIBA 01/2021 - 01/2021
2	purineIBA 01/2021 - 01/2021
2	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019 - 01/2017
1	HomocysteineIBA 11/2023
1	MelatoninIBA 10/2023
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Warfarin (Coumadin)FDA LinkGeneric 02/2022
1	VaccinesIBA 02/2022
1	ConvulsantsIBA 01/2022
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Lorazepam (Ativan)FDA LinkGeneric 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022
1	ITH15004IBA 01/2022
1	Colchicine FDA LinkGeneric 08/2021
1	Cardiovascular AgentsIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	AcidsIBA 01/2021
1	PurinesIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Purinergic P2 Receptors (ADP Receptor)IBA 01/2021
1	CytokinesIBA 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Anti-Arrhythmia AgentsIBA 01/2021
1	Coffee FDA Link 11/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	2- iodo- N(6)- methyl- (N)- methanocarba- 2'- deoxyadenosine- 3',5'- bisphosphateIBA 01/2019
1	(N)-methanocarba-2MeSADPIBA 01/2019
1	purinoceptor P2Y4IBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2018

Therapy/Procedure

4	Therapeutics 10/2023 - 01/2019
1	Intravenous Injections 01/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Contraindications 01/2022
1	Secondary Prevention 01/2021
1	Polypharmacy 01/2021
1	Surgical Amputation (Amputations) 01/2020